For each company, the report provides:Annual R&D budget.Research facilities and staff.New technologies, drugs, and indications in development, including their phase and anticipated introduction dates.The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis - Pfizer - Roche - Sanofi-Aventis - WyethContains 160 pages